Watchdog: Yet Again, U.S. Chamber Went Judge Shopping in Conservative 5th Circuit Territory to Keep Workers From Getting a Raise
Justice Kavanaugh Past Comments Reveal Contradictions on Presidential Immunity
Watchdog: New FTC Rule Would Boost Earnings for Millions of Americans Despite Industry Objections
Analysis: Senate Republicans Took Big Checks From Big Banks Weeks Before Co-Sponsoring Resolution to Protect $41 Credit Card Late Fees
New Reports Show Massive Big Pharma Influence-Peddling to Stop President Biden’s Medicare Drug Price Negotiation
Site Menu

NYT: “Pfizer…released only sparse details from its clinical trial…scientists have cautioned against hyping early results”

 Washington, DC – Today, watchdog and patient advocacy group Accountable Pharma released the following statement on the announcement by Pfizer that early data suggests that their COVID-19 vaccine is 90% effective, calling on them to release their data for independent review. Accountable Pharma also called for the company to implement a freeze on the sale of stocks and options by executives and directors to prevent the kind of insider profiteering off of positive news that we’ve seen across the industry over the last few months.

“This is incredible news for patients and families across the country who are desperate for this pandemic to end, but it’s important to remember that these are just initial, non-verified results from a drug company with a history of manipulating studies and illegally promoting their products,” said Eli Zupnick, spokesman for Accountable Pharma. “Pfizer should immediately release their study data for full independent review and implement a freeze on any stock sales by executives and directors to prevent insiders from cashing out before we know if this vaccine truly works.”

“Especially given the billions of guaranteed taxpayer dollars that supported and incentivized the development of this vaccine, Pfizer must now explain how much they intend to profiteer off of this vaccine and what they intend to charge patients and the federal government beyond the initial doses.” 

In September, Accountable Pharma released a report revealing that top executives and directors at five top drug companies receiving billions of taxpayer dollars through Operation Warp Speed have made more than $145 million cashing out their stock options between the launch of Operation Warp Speed on May 15th and the end of August 2020. 

###

back to top